133 related articles for article (PubMed ID: 18213447)
1. Proteomics in nasopharyngeal carcinoma.
Li F; Guan Y; Chen Z
Cell Mol Life Sci; 2008 Apr; 65(7-8):1007-12. PubMed ID: 18213447
[No Abstract] [Full Text] [Related]
2. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
3. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.
Liu Z; Chen C; Yang H; Zhang Y; Long J; Long X; Fang W
Proteomics; 2012 Nov; 12(22):3416-25. PubMed ID: 22997098
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.
Chen ZT; Li L; Guo Y; Qu S; Zhao W; Chen H; Su F; Yin J; Mo QY; Zhu XD
Oncol Rep; 2015 Nov; 34(5):2477-88. PubMed ID: 26352878
[TBL] [Abstract][Full Text] [Related]
5. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
Feng X; Zhang J; Chen WN; Ching CB
J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of protein expression profile of laser capture microdissection-purified nasopharyngeal carcinoma tissue].
Peng F; Tang C; Li M; Li C; Chen A; Li F; Zhang P; Li M; Xiao Z; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):481-6. PubMed ID: 19587428
[TBL] [Abstract][Full Text] [Related]
7. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal Carcinoma Protein Interaction Mapping Analysis via Proteomic Approaches.
Zamanian Azodi M; Rezaei Tavirani M; Rezaei Tavirani M; Vafaee R; Rostami-Nejad M
Asian Pac J Cancer Prev; 2018 Mar; 19(3):845-851. PubMed ID: 29582644
[TBL] [Abstract][Full Text] [Related]
9. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
10. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
11. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
13. [Differential proteomic analysis of nasopharyngeal carcinoma cell lines 5-8F and 6-10B].
Xiang YL; Yi H; Li C; Zhang PF; Li MY; Chen ZC; Xiao ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):978-84. PubMed ID: 18182713
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
15. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
16. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of a nasopharyngeal carcinoma cell line and a nasopharyngeal epithelial cell line.
Huang PY; Zeng TT; Li MQ; Ban X; Zhu YH; Zhang BZ; Mai HQ; Zhang L; Guan XY; Li Y
Tumori; 2015; 101(6):676-83. PubMed ID: 26108243
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase IIa deregulation in nasopharyngeal carcinoma.
Papanikolaou V; Chrysovergis A; Tsiambas E; Kyrodimos E
J BUON; 2019; 24(4):1736. PubMed ID: 31646836
[No Abstract] [Full Text] [Related]
19. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
Janvilisri T
Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3γ as a novel biomarker in nasopharyngeal carcinoma.
Wu Z; Weng D; Li G
J Proteomics; 2013 May; 83():26-36. PubMed ID: 23500129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
